Remove Compliance Remove FDA Remove Nursing Homes
article thumbnail

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

The company’s Carnation Ambulatory Monitor (CAM) Patch is a P-wave centric ambulatory cardiac monitor and arrhythmia detection device that also is designed to improve patient compliance for both adults and children through its lifestyle-enabling form factor. iRhythm Technologies.

COVID-19 216
article thumbnail

Keys to managing Point-of-Care Testing Compliance

MedTrainer

Keys to managing point-of-care testing compliance. In an effort to combat the spread of the virus and to help nursing homes protect the health and safety of their residents, the U.S. To be eligible, nursing homes must have a current CLIA Certificate of Waiver and meet certain epidemiological criteria.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Keys to managing Point-of-Care Testing Compliance

MedTrainer

Keys to managing Point-of-Care Testing Compliance. Keys to managing point-of-care testing complianceIn an effort to combat the spread of the virus and to help nursing homes protect the health and safety of their residents, the U.S.

article thumbnail

Ensuring Safety and Quality in America’s Nursing Homes

CMS.gov

Ensuring Safety and Quality in America’s Nursing Homes. Nursing facilities. This duty is especially important when it comes to the care provided for some of the most vulnerable in our society, Americans residing in nursing homes. CMS’ approach to oversight of nursing homes is constantly evolving.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – June

SQA

ISPE Good Practice Guide: Critical Utilities GMP Compliance. United States Food and Drug Administration (FDA) – Regulations and Guidances. FDA Proposes Benefit-Risk Considerations for Product Quality Assessments, 20 June 2022. ISPE Good Practice Guide: Ozone Sanitization of Pharmaceutical Water Systems .

FDA 91
article thumbnail

FDA Guidance Provides Relief for MDR Reporting During a Pandemic

Exeed Regulatory Compliance

A new FDA guidance provides much-needed relief during a pandemic. FDA has just revised its relatively less known 2012 guidance entitled “Post-market Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic” to clarify that the guidance is applicable to any pandemic, not just an influenza pandemic.

FDA 52
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – Spring

SQA

China Regulatory Roundup: Latest Guidelines for Medical Device and IVD Compliance, 17 March 2022. United States Food and Drug Administration (FDA) – Regulations and Guidances. Guidance for Industry: Certain Ophthalmic Products: Policy Regarding Compliance with 21 CFR Part 4, March 2022.

FDA 75